Slankstelis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 68,017 | 118,594 | 162,273 | 299,773 | 441,838 | 554,647 | 687,173 | 834,986 |
| Profit before tax | - | - | - | - | - | - | 82,970 | 122,025 |
| Net profit | 8,662 | 36,109 | 58,101 | 53,958 | 89,731 | 55,904 | 70,212 | 102,501 |
| Equity | 8,556 | 24,957 | 61,058 | 33,589 | 57,022 | 65,757 | 49,395 | 66,754 |
| Liabilities | 21,982 | 4,651 | 16,637 | 25,670 | 38,536 | 49,307 | 54,109 | 56,513 |
| Non-current assets | 5,154 | 3,578 | 11,972 | 21,102 | 18,285 | 23,431 | 31,162 | 21,547 |
| Current assets | 20,656 | 23,454 | 61,817 | 38,157 | 77,273 | 91,633 | 72,342 | 101,720 |
| Total assets | 25,810 | 27,032 | 73,789 | 59,259 | 95,558 | 115,064 | 103,504 | 123,267 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 102,138 | 114,443 | 127,241 |
| Social insurance contributions | - | - | - | - | - | 81,529 | 101,726 | 117,882 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +34.6% | +74.4% | +36.8% | +84.7% | +47.4% | +25.5% | +23.9% | +21.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 33.6% | 133.6% | 78.7% | 91.1% | 93.9% | 48.6% | 67.8% | 83.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 101.2% | 144.7% | 95.2% | 160.6% | 157.4% | 85.0% | 142.1% | 153.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 12.7% | 30.4% | 35.8% | 18.0% | 20.3% | 10.1% | 10.2% | 12.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | 12.1% | 14.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.6 | 0.2 | 0.3 | 0.8 | 0.7 | 0.7 | 1.1 | 0.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 17,004 | 23,719 | 26,675 | 38,269 | 42,080 | 46,544 | 53,546 | 69,582 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Slankstelis - Social security debts
The company had no debts to Sodra
Slankstelis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-09-19 | 2024-12-11 | 0.06 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Slankstelis, UAB (code 304227824) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the latest financial year, the company generated revenue of €835.0K and net profit of €102.5K, with a profit margin of 12.3%. Revenue increased by 21.5% year on year, and over two years it rose by 50.5%, showing a clear upward trajectory. Profit also improved steadily from €55.9K in 2023 to €70.2K in 2024 and €102.5K in 2025. The margin remained close to 10% in 2023 and 2024 before strengthening in 2025. At the end of 2025, total assets stood at €123.3K, equity at €66.8K and liabilities at €56.5K. The equity ratio was 54.1% and debt to equity was 0.85, indicating a balanced capital structure. Asset turnover reached 6.77x, while revenue per employee was €69.6K and profit per employee was €8.5K, pointing to solid operating efficiency.